EXTRACORPOREAL PHOTOPHERESIS AS TREATMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION: A SINGLE CENTRE EXPERIENCE

被引:0
|
作者
Benazzo, A. [1 ]
Schwarz, S. [1 ]
Schweiger, T. [1 ]
Hoetzenecker, K. [1 ]
Lambers, C. [1 ]
Murakoezy, G. [1 ]
Taghavi, S. [1 ]
Klepetko, W. [1 ]
Jaksch, P. [1 ]
机构
[1] Med Univ Wien, Vienna, Austria
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
O23
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
  • [1] OUTCOMES FOLLOWING EXTRACORPOREAL PHOTOPHERESIS FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION FOLLOWING LUNG TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
    Vazirani, Jaideep
    Routledge, David
    Snell, Greg I.
    Watson, Doug
    Paraskeva, Miranda
    Westall, Glen P.
    Harrison, Simon J.
    TRANSPLANTATION, 2020, 104 (09) : S590 - S590
  • [2] Comparison of Extracorporeal Photopheresis and Thymoglobulin for the Treatment of Chronic Lung Allograft Dysfunction
    Martos Gisbert, N.
    Aguilar, M.
    Laporta, R.
    Lazaro, M.
    Aguado, S.
    Sandoval, R.
    Ussetti Gil, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S445 - S446
  • [3] Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction
    Moniodis, Anna
    Townsend, Keri
    Rabin, Alexander
    Aloum, Obadah
    Stempel, Jessica
    Burkett, Patrick
    Camp, Phillip
    Divo, Miguel
    El-Chemaly, Souheil
    Mallidi, Hari
    Rosas, Ivan
    Fuhlbrigge, Anne
    Koo, Sophia
    Goldberg, Hilary J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03): : 340 - 348
  • [4] Efficacy and Safety if JAK2 Inhibitor Plus Extracorporeal Photopheresis in Chronic Lung Allograft Dysfunction: A Single Centre Experience
    Negigowda, M.
    Rahulan, V.
    Lalani, M.
    Tisekar, O.
    Priyaranjan, S.
    Dutta, P.
    Mohandas, A.
    Sameer, M.
    Attawar, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S134 - S134
  • [5] Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience
    Teszak, Timea
    Assabiny, Alexandra
    Kiraly, Akos
    Tarjanyi, Zoltan
    Parazs, Nora
    Szakal-Toth, Zsofia
    Hartyanszky, Istvan
    Szabolcs, Zoltan
    Racz, Kristof
    Reti, Marienn
    Merkely, Bela
    Sax, Balazs
    TRANSPLANT IMMUNOLOGY, 2023, 79
  • [6] Extracorporeal Photopheresis (ECP) in the Management of Chronic Lung Allograft Dysfunction
    Furuya, Y.
    Witt, C.
    Trulock, E. P.
    Byers, D.
    Kulkarni, H.
    Tague, L. K.
    Aguilar, P.
    Kreisel, D.
    Puri, V.
    Gelman, A.
    Hachem, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S165 - S166
  • [7] Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience
    Vazirani, Jaideep
    Routledge, David
    Snell, Greg, I
    Watson, Doug
    Paraskeva, Miranda
    Westall, Glen P.
    Harrison, Simon J.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (01) : 296 - 302
  • [8] IMPACT OF EXTRACORPOREAL PHOTOPHERESIS ON LUNG FUNCTION AND MORTALITY IN CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Wahab, Abdul
    Wylam, Mark E.
    Yadav, Hemang
    Peters, Steve G.
    Scott, John Pau
    Kennedy, Cassie C.
    Winters, Jeffrey
    Pennington, Kelly
    CHEST, 2023, 164 (04) : 6420A - 6421A
  • [9] Extracorporeal Photopheresis as Treatment Option of Chronic Lung Allograft Dysfunction. Is ECP the Therapy of the Future?
    Benazzo, A.
    Landl, M.
    Mockenhuber, M.
    Schwarz, S.
    Murakoezy, G. O.
    Lambers, C. O.
    Moser, B.
    Hoetzenecker, K.
    Siguenza, J. O. Matilla
    Lang, G. O.
    Taghavi, S.
    Klepetko, W.
    Jaksch, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S110 - S110
  • [10] Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction
    Gautschi, Fiorenza
    Vogelmann, Tobias
    Ortmanns, Gernot
    Knoerr, Fabian
    Steinack, Carolin
    Hage, Rene
    Naegeli, Mirjam
    Schuurmans, Mace Matthew
    JOURNAL OF CLINICAL APHERESIS, 2024, 39 (03)